Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of calcium antagonists.

T Godfraind

    The American Journal of Cardiology
    |January 30, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Calcium antagonists, including calcium entry blockers, are classified based on their molecular interactions with calcium channels. This pharmacologic classification supports their clinical use in conditions like angina.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Calcium channel blockers and tissue remodeling in hypertension].

    Bulletin et memoires de l'Academie royale de medecine de Belgique·2002
    Same author

    Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats.

    British journal of pharmacology·2001
    Same author

    New insights into the therapeutic mechanism of action of calcium channel blockers in salt-dependent hypertension: their interaction with endothelin gene expression.

    Journal of cardiovascular pharmacology·2001
    Same author

    Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats.

    Hypertension (Dallas, Tex. : 1979)·2001
    Same author

    Carvedilol and lacidipine prevent cardiac hypertrophy and endothelin-1 gene overexpression after aortic banding.

    Hypertension (Dallas, Tex. : 1979)·1999
    Same author

    Effect of nitro-L-arginine on electrical and mechanical responses to acetylcholine in the superior mesenteric artery from stroke-prone hypertensive rat.

    British journal of pharmacology·1999
    Same journal

    Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

    The American journal of cardiology·2026
    Same journal

    ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

    The American journal of cardiology·2026
    Same journal

    Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

    The American journal of cardiology·2026
    Same journal

    Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

    The American journal of cardiology·2026
    Same journal

    Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

    The American journal of cardiology·2026
    Same journal

    Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

    The American journal of cardiology·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Cell Biology

    Background:

    • Calcium antagonists represent diverse chemical families with significant therapeutic applications.
    • Understanding their pharmacologic properties is crucial for accurate classification and clinical application.

    Purpose of the Study:

    • To clarify the terminology and classification of calcium antagonists.
    • To provide a pharmacologic rationale for the clinical use of these drugs.
    • To support a classification system based on molecular, tissue, and organ-level studies.

    Main Methods:

    • Examined pharmacologic properties of various calcium antagonists.
    • Utilized studies on nifedipine's interaction with human coronary artery calcium channels.
    • Employed cell biology for identifying agents modulating calcium movements.

    Related Experiment Videos

    Main Results:

    • Calcium entry blockers are defined by their ability to block calcium influx.
    • Selective calcium entry blockers include myocardial slow channel blockers (verapamil, nifedipine, diltiazem) and arterial-selective agents (cinnarizine, flunarizine).
    • Nonselective agents and those with other primary actions were also identified and classified.

    Conclusions:

    • A pharmacologic classification of calcium antagonists, based on their interaction with calcium channels and other cellular mechanisms, is proposed.
    • This classification aligns with the observed clinical efficacy of these drugs, particularly in angina treatment.
    • The study supports a multi-level approach (molecular, tissue, organ) for classifying calcium antagonists.